OUR LOCATION

Dubai, UAE

+91 9977002116

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Advanced Technologies » HAD-3891116

  • Soft Tissue Repair

  • Publish: October 2016 | Report Code: HAD-3891116

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

The global protein engineering market is  expected to grow at a CAGR of 15.7% between 2016-2023. Protein engineering is the process of the development of new, useful and valuable protein. Protein engineering can be achieved by mainly two techniques namely rational protein designing and directed evaluation protein designing. Proteins have the property of possessing a dynamic ability of less immunogenicity and high specificity and by using this ability protein can be engineered in such a way that they can be used as a therapeutic agent. Due to the advancement in technology unnatural proteins (amino acids) can also be used for protein engineering. This technique apart from the field of therapeutics can also be applied in detergent, food and industrial products. Some of the major factors which are responsible for driving the market are Increasing prevalence for chronic diseases due to deficiency of proteins along with change in preference among consumer for protein drug over non-protein drug. Owing to the high versatility protein drugs are gaining more popularity in the global market as compared to non-protein drugs. Moreover, rapidly rising incidences of lifestyle diseases along with the technological advancements in the exploration of drug such as mass spectrometry are also contributing for the market growth of protein engineering. In past year’s advancement in recombinant DNA like phage display have contributed for growing demand for protein based drugs globally. Along with this increasing support by the government through funding for protein engineering, rising aging population and reduction in prices of drug are estimated to drive the demand for the market of protein engineering globally.

The market includes several driving factors for it, but although there are some of the challenges which are faced by protein engineering market such as lack of trained professionals along with high costing of engineering instrument and their high maintenance cost of its tools and instruments are hindering the market growth. Moreover, high research and development funds, high probability of meeting the failure of the research, stringent rules, technological limitations and lack of awareness among people are some of the other factors which are proven to be the restraints for the market growth of protein engineering globally.

Source: OBRC Analysis

The global protein engineering market is segmented on the basis of product, technology, protein type and end user. On the basis of product, the market is sub segmented into:

  • Reagents
  • Instrument
  • Services and software




On the basis of technology, the market is sub segmented into:

  • Rational protein design
  • Irrational protein design



On the basis of protein type the market is sub segmented into:

  • Insulin
  • Monoclonal
  • Erythropoietin
  • Colony stimulating factor
  • Interferon
  • Growth hormones
  • Coagulation factor
  • Vaccines
  • Other types of protein










On the basis of end user, the protein engineering market is sub segmented into:

  • Pharmaceutical and biotechnology companies
  • Academic research institutes
  • Contract research organizations




The revenue for the end user segment are specific to the global protein engineering market. However, the total revenue of these end-user in general has been excluded from the scope of the report. Geographically, the global Protein engineering market has been segmented on the basis of four major region, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is dominating region in protein engineering market due to the increasing various research activities along with government initiatives. Due to increasing demand for protein based drug and advancement in technology Europe is considered to be the second largest market for protein engineering globally. However, due to the increasing investment by government for the improvement of healthcare infrastructure Asia Pacific is growing fastest for protein engineering market. Also increasing techniques for protein engineering can also contribute in market growth in Asia Pacific.

The global protein engineering market is segmented on the basis of product, on the basis of technology, on the basis of type of protein, on the basis of end user. On the basis of product, the market is sub segmented into reagents, instrument, services and software. On the basis of technology, the market is sub segmented in to rational protein design and irrational protein design. On the basis of protein type the market is sub segmented in to insulin, monoclonal, erythropoietin, colony stimulating factor, interferon, growth hormones, coagulation factor, vaccines, and other types of protein. On the basis of end user, the protein engineering market is sub segmented by pharmaceutical and biotechnology companies, Academic Research institutes, contract research organizations. In protein type monoclonal antibodies is among the fastest growing segment due to its increased adoption for various therapies such as cancer and autoimmune diseases. In technology rational protein design was considered to be highly adopted technology in 2014 owing a lead over irrational protein design technology. In end user Pharmaceutical and biotechnology industries are estimated to the largest consumer for the protein engineering market. The growth for these industries are attributed by the increase in budgets of R&D and advancement in technology in pharmaceutical and biotechnology sector.

The major market players of the global protein engineering market are:

  • AGILENT TECHNOLOGIES, INC.
  • BIO-RAD LABORATORIES, INC.
  • GE HEALTHCARE
  • GLAXOSMITHKLINE INC.
  • SIGMA-ALDRICH CORPORATION
  • THERMO FISHER SCIENTIFIC, INC







Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching.  In June 2016, Novartis which is one of the largest pharmaceutical company had a collaboration with Xencor, a biopharmaceutical company which develops engineered monoclonal antibodies. The collaboration is made by Novartis to strengthen its immune oncology pipeline. Moreover,

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as collaboration that is In June 2016, Novartis which is one of the largest pharmaceutical company had a collaboration with Xencor, a biopharmaceutical company which develops engineered monoclonal antibodies.
  • Provide in detail the different segments such as by product, technology, protein type and end user which are affecting the global protein engineering market.
  • Provide you the patent analysis of the protein engineering market.
  • Identify and understand the strength, opportunities, challenges and threat of the protein engineering market.
  • Provide revenues of major players of the market such as  Agilent technologies, inc., Bio-rad laboratories, inc.
  • Provide you various the regulatory policies which are affecting the global protein engineering market.







How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global protein engineering market offers the longest chain of market segmentation covering major market segmentation based on products, technology, protein type and end users. The report tracks the major market trends in the global protein engineering market such as  technological advancement,  increasing R&D investment and so on.  For each market segments covered in global protein engineering market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the  protein engineering industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key Findings of the global protein engineering market:

  • Protein engineering can be achieved by mainly two techniques namely rational protein designing and directed evaluation protein designing.
  • North America is anticipated to account the largest revenue share in 2016.
  • Rapidly rising incidences of lifestyle diseases along with the technological advancements in the exploration of drug such as mass spectrometry are also contributing for the market growth of protein engineering.
  • Increasing government support
  • Collaboration is the key strategy adopted by the various market players of global protein engineering market.
  •  Pharmaceuticals and biotechnology is the major segment of end user.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL PROTEIN ENGINEERING MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RISE IN ADOPTION OF PROTEIN BASED DRUGS
3.1.2.      INCREASING PREVALENCE OF LIFE STYLE DISEASES
3.1.3.     INCREASING FUNDING FOR PROTEIN BASED ENGINEERING
3.1.4.      REDUCTION IN COST FOR DISCOVERY OF DRUG
3.2. MARKET RESTRAINTS
3.2.1. EXPENSIVE AND HIGH MAINTENANCE TOOLS AND INSTRUMENT IN PROTEIN ENGINEERING
3.3. MARKET OPPORTUNITIES
3.3.1. PROTEIN THERAPY AS AN ALTERNATIVE TO GENE THERAPY
3.3.2.     SIGNIFICANT GROWTH IN EMERGING ECONOMIES
3.4.   MARKET CHALLENGES 
3.4.1. NEED FOR MANDATORY TRAINING AND QUALIFIED RESEARCHERS IN PROTEIN ENGINEERING
3.4.2.     HIGH PROCESS COST
 
4. MARKET SEGMENTATION 
4.1. GLOBAL PROTEIN ENGINEERING MARKET BY PRODUCT
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL REAGENTS MARKET 
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL INSTRUMENT MARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL SERVICES AND SOFTWARE MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL PROTEIN ENGINEERING MARKET BY TECHNOLOGY 
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL RATIONAL PROTEIN DESIGN MARKET 
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL IRRATIONAL PROTEIN DESIGN MARKET 
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.4. KEY CONCLUSIONS
4.3. GLOBAL PROTEIN ENGINEERING MARKET BY PROTEIN TYPE 
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL INSULIN MARKET 
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL MONOCLONAL MARKET 
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL ERYTHROPOIETIN MARKET 
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.3.4. KEY CONCLUSIONS
4.3.5.4. GLOBAL COLONY STIMULATING FACTOR MARKET 
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.4.4. KEY CONCLUSIONS
4.3.5.5. GLOBAL INTERFERON MARKET 
4.3.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.5.4. KEY CONCLUSIONS
4.3.5.6. GLOBAL GROWTH HORMONES MARKET 
4.3.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.6.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.6.4. KEY CONCLUSIONS
4.3.5.7. GLOBAL COAGULATION FACTOR MARKET 
4.3.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.7.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.7.4. KEY CONCLUSIONS
4.3.5.8. GLOBAL VACCINES MARKET 
4.3.5.8.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.8.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.8.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.8.4. KEY CONCLUSIONS
4.3.5.9. GLOBAL OTHER TYPES OF PROTEIN MARKET 
4.3.5.9.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.9.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.9.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.9.4. KEY CONCLUSIONS
4.4. GLOBAL PROTEIN ENGINEERING MARKET BY   END USER
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL   PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL   ACADEMIC RESEARCH INSTITUTES MARKET 
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL    CONTRACT RESEARCH ORGANIZATIONS MARKET 
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.3.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL PROTEIN ENGINEERING   MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. AGILENT TECHNOLOGIES, INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. DANAHER CORPORATION
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. BIO-RAD LABORATORIES, INC.
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. BRUKER CORPORATION
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS 
7.4.5. STRATEGIC ANALYSIS
7.5. SIGMA-ALDRICH CORPORATION
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. GENERAL ELECTRIC COMPANY
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.6.5. STRATEGIC ANALYSIS
7.7. GENSCRIPTS, INC.
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. PERKINELMER, INC.
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. THERMO FISHER SCIENTIFIC, INC.
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. WATERS CORPORATION.
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. AB SCIEX
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. NOVARTIS AG
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13.   GLAXOSMITHKLINE INC
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. ELI LILLY AND COMPANY
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. JOHNSON AND JOHNSON 
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL PROTEIN ENGINEERING MARKET BY PRODUCT 2014-2023 ($ MILLION)
2. GLOBAL REAGENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL INSTRUMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL SERVICES AND SOFTWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL PROTEIN ENGINEERING MARKET BY TECHNOLOGY  2014-2023 ($ MILLION)
6. GLOBAL RATIONAL PROTEIN DESIGN   MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL IRRATIONAL PROTEIN DESIGN   MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL PROTEIN ENGINEERING MARKET BY PROTEIN TYPE 2014-2023 ($ MILLION)
9. GLOBAL INSULIN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL MONOCLONAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL ERYTHROPOIETIN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL COLONY STIMULATING FACTOR MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL INTERFERON MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL GROWTH HORMONES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL COAGULATION FACTOR MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL VACCINES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. GLOBAL PROTEIN ENGINEERING MARKET BY END USER 2014-2023 ($ MILLION)
18. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
19. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
20. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
21. NORTH AMERICA PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
22. EUROPE PROTEIN ENGINEERING   MARKET 2014-2023 ($ MILLION)
23. ASIA PACIFIC PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
24. REST OF THE WORLD PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL REAGENTS MARKET 2014-2023 ($ MILLION)
2. GLOBAL INSTRUMENT MARKET 2014-2023 ($ MILLION)
3. GLOBAL SERVICES AND SOFTWARE MARKET 2014-2023 ($ MILLION)
4. GLOBAL RATIONAL PROTEIN DESIGN MARKET 2014-2023 ($ MILLION)
5. GLOBAL IRRATIONAL PROTEIN DESIGN MARKET 2014-2023 ($ MILLION)
6. GLOBAL INSULIN MARKET   2014-2023 ($ MILLION)
7. GLOBAL MONOCLONAL MARKET   2014-2023 ($ MILLION)
8. GLOBAL ERYTHROPOIETIN MARKET   2014-2023 ($ MILLION)
9. GLOBAL COLONY STIMULATING FACTOR MARKET  2014-2023 ($ MILLION)
10. GLOBAL INTERFERON MARKET   2014-2023 ($ MILLION)
11. GLOBAL GROWTH HORMONES MARKET   2014-2023 ($ MILLION)
12. GLOBAL COAGULATION FACTOR MARKET  2014-2023 ($ MILLION)
13. GLOBAL VACCINES MARKET   2014-2023 ($ MILLION)
14. GLOBAL OTHER TYPES OF PROTEIN MARKET
15. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET   2014-2023 ($ MILLION)
16. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET  2014-2023 ($ MILLION)
17. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET   2014-2023 ($ MILLION)
18. UNITED STATES (U.S.) PROTEIN ENGINEERING   MARKET 2014-2023 ($ MILLION)
19. CANADA PROTEIN ENGINEERING   MARKET 2014-2023 ($ MILLION)
20. UNITED KINGDOM (UK) PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
21. FRANCE PROTEIN ENGINEERING   MARKET 2014-2023 ($ MILLION)
22. GERMANY PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
23. SPAIN PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
24. ROE PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
25. INDIA PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
26. CHINA PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
27. JAPAN PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
28. AUSTRALIA PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
29. ROAPAC PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
30. LATIN AMERICA PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
31. MENA PROTEIN ENGINEERING MARKET 2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

 

+91 8390547755

UPCOMING REPORTS

No upcoming reports available under this subcategory.